SciELO - Scientific Electronic Library Online

 
vol.55 número2Manifestaciones Extra pulmonares de la infección por SARS-CoV-2 en Pediatría. RevisiónArmando el Rompecabezas Fisiopatológico del COVID-19 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Anales de la Facultad de Ciencias Médicas (Asunción)

versión impresa ISSN 1816-8949

Resumen

ARELLANO, Nelson et al. Major vascular resection for pancreatic ductal adenocarcinoma: case report, of first case reported in Paraguay. An. Fac. Cienc. Méd. (Asunción) [online]. 2022, vol.55, n.2, pp.97-104. ISSN 1816-8949.  https://doi.org/10.18004/anales/2022.055.02.97.

Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer death and is projected to rank second by 2030. The prognosis is bleak, with survival being less than 9% in 5 years. For a long time, surgical resection was considered the only curative treatment, however, only 15 to 20% of patients can benefit from it. The most widely used pre-therapeutic classification is that of the National Comprehensive Cancer Network (NCCN), based on the relationship of the tumor with vascular structures, classifying them into “resectable”, “borderline” and “locally advanced” tumors. We present the first registered case in Paraguay of PDA with infiltration of the Superior Mesenteric Vein (SMV) treated with cephalic duodenopancreatectomy (CPD) associated with major vascular resection.

Palabras clave : Pancreatic ductal adenocarcinoma; Resectable Pancreatic Cancer Borderline; Duodenopancreatectomy; Portal vein resection; neoadjuvant chemotherapy..

        · resumen en Español     · texto en Español     · Español ( pdf )